A new study from the UK shows HPV vaccine uptake plummeting, partly due to a lack of confidence in public health.
New Zealand has used the HPV vaccine as a preventive to cervical and other cancers for nearly 20 years, with a recent study showing the vaccine cuts the risk of developing cervical cancer by up to two thirds.
Is our cervical cancer rate in jeopardy due to a fractured faith in vaccinations?
Emile Donovan speaks to Professor Bev Lawton ONZM, the founder and director of the National Centre for Women's Health Research Aotearoa, and the 2025 New Zealander of the Year.
A woman receives an HPV vaccination Photo: SCIENCE PHOTO LIBRARY
